It is worth noting that insulin secretagogues are usually prescribed to young adult patients (i.e., patients with pre-diabetes or a new diagnosis of T2D) due to the enhanced risk of hypoglycemia in aged people. This evidence concerns the gene INS and diabetes mellitus.